asco.org3d
Conflict of Interest (COI)
The American Society of Clinical Oncology (ASCO) is a professional oncology society committed to conquering cancer through research, education, prevention, and the delivery of high-quality patient ...
asco.org4d
Topical Mentoring Opportunities
Throughout the year, members can sign-up to participate in virtual meetings focused on specific training or career topics. Members can select from a list of mentors per meeting topic. At the end of ...
asco.org4d
The Conquer Cancer Patient Advocate Scholarship Program
The scholarship application period for the 2025 ASCO Annual Meeting will open on Monday, March 10 at 10:00 AM and close on Monday, March 17 at 5:00 PM (ET). Please read the eligibility and criteria ...
asco.org5d
Resilience Skills Training Program
The Resilience Skills Training Program aims to improve physician wellness in oncology through a proactive approach. The program targets current trainees to help create a culture change surrounding ...
asco.org5d
Staff Well-Being & Development
Recruiting and developing oncology practice staff takes care and strategy. ASCO can be a unique resource as you search for ideal candidates and work to bolster the expertise and efficiency of your ...
asco.org5d
Similar Posters
Association of early completion of portable medical orders with inpatient costs at end-of-life for patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
asco.org5d
The effect of anti-cancer therapy on immunological response to COVID-19 vaccination.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org5d
Tumor suppressor genes (TSG), treatment, and survival in de novo metastatic hormone-sensitive prostate cancer.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org6d
Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US): NRG-GI008.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org6d
Clinical characterization and therapeutic outcomes of patients (pts) with colorectal cancer (CRC) harboring somatic BRCA1/2 mutations.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org6d
Tumor-educated platelets for breast cancer detection: Biological and technical insights.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org6d
Real world outcomes of sequential ADC therapy in metastatic breast cancer: Patients treated with sacituzumab govitecan and trastuzumab deruxtecan.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...